Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Genetic Technologies Limi...

    NASDAQ: GENE · Real-Time Price · USD
    0.77
    0.01 (0.65%)
    At close: Nov 14, 2024, 9:00 PM

    Genetic Statistics

    Share Statistics

    Genetic has 145.42M shares outstanding. The number of shares has increased by 75.32% in one year.

    Shares Outstanding

    n/a
    		 145.42M

    Shares Change (YoY)

    n/a
    		 75.32%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 0%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 n/a

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -0.78 and the forward PE ratio is null. Genetic's PEG ratio is 0.01.

    PE Ratio

    n/a
    		 -0.78

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 1.22

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 5.1

    P/FCF Ratio

    n/a
    		 -0.96

    PEG Ratio

    n/a
    		 0.01
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Genetic.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 0.88, with a Debt / Equity ratio of 0.48.

    Current Ratio

    n/a
    		 0.88

    Quick Ratio

    n/a
    		 0.83

    Debt / Equity

    n/a
    		 0.48

    Debt / EBITDA

    n/a
    		 -0.08

    Debt / FCF

    n/a
    		 -0.09

    Interest Coverage

    n/a
    		 -126.64

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $139,359.71

    Profits Per Employee

    n/a
    		 $-218,494.89

    Employee Count

    n/a
    		 55

    Asset Turnover

    n/a
    		 1.24

    Inventory Turnover

    n/a
    		 18.21

    Taxes

    Income Tax

    n/a
    		 n/a

    Effective Tax Rate

    n/a
    		 0%

    Stock Price Statistics

    The stock price has increased by null% in the last 52 weeks. The beta is 0.48, so Genetic's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.48

    52-Week Price Change

    n/a
    		 n/a

    50-Day Moving Average

    n/a
    		 0.76

    200-Day Moving Average

    n/a
    		 1.48

    Relative Strength Index (RSI)

    n/a
    		 47.23

    Average Volume (20 Days)

    n/a
    		 n/a

    Income Statement

    In the last 12 months, Genetic had revenue of 7.66M and earned -12.02M in profits. Earnings per share was -0.09.

    Revenue

    n/a
    		 7.66M

    Gross Profit

    n/a
    		 3.9M

    Operating Income

    n/a
    		 -6.54M

    Net Income

    n/a
    		 -12.02M

    EBITDA

    n/a
    		 -11.43M

    EBIT

    n/a
    		 -11.97M

    Earnings Per Share (EPS)

    n/a
    		 -0.09
    Full Income Statement

    Balance Sheet

    The company has 1.02M in cash and 875.19K in debt, giving a net cash position of 145.42K.

    Cash & Cash Equivalents

    n/a
    		 1.02M

    Total Debt

    n/a
    		 875.19K

    Net Cash

    n/a
    		 145.42K

    Retained Earnings

    n/a
    		 -166.38M

    Total Assets

    n/a
    		 6.19M

    Working Capital

    n/a
    		 -500.09K
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -9.68M and capital expenditures -32.97K, giving a free cash flow of -9.71M.

    Operating Cash Flow

    n/a
    		 -9.68M

    Capital Expenditures

    n/a
    		 -32.97K

    Free Cash Flow

    n/a
    		 -9.71M

    FCF Per Share

    n/a
    		 -0.07
    Full Cash Flow Statement

    Margins

    Gross margin is 50.94%, with operating and profit margins of -85.29% and -156.78%.

    Gross Margin

    n/a
    		 50.94%

    Operating Margin

    n/a
    		 -85.29%

    Pretax Margin

    n/a
    		 -156.78%

    Profit Margin

    n/a
    		 -156.78%

    EBITDA Margin

    n/a
    		 -149.13%

    EBIT Margin

    n/a
    		 -85.29%

    FCF Margin

    n/a
    		 -126.71%

    Dividends & Yields

    GENE does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for GENE.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Dec 14, 2023. It was a backward split with a ratio of 1:5.

    Last Split Date

    n/a
    		 Dec 14, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:5

    Scores

    Altman Z-Score

    n/a
    		 -32.15

    Piotroski F-Score

    n/a
    		 2

    Add to Watchlist